3. WHO. Neural Tube Defects: Health Situation in the South-East Asia Region. World Health Organization; 2021.
[4]
4. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med. 1999;341(20):1509-1519.
[5]
5. Greene ND, Stanier P, Moore GE. The emerging role of folate in neural tube defects. Trends Mol Med. 2011;17(6):315-322.
[6]
6. Detrait ER, George TM, Etchevers HC, et al. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005;27(3):515-524.
[7]
7. Khoshnood B, Loane M, de Walle H, et al. Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ. 2015;351:h5949.
[8]
8. CDC. Folic Acid and Neural Tube Defects: Recommendations and Requirements. MMWR. 1991;40(RR-13):1-7.
[9]
9. Au KS, Ashley-Koch A, Northrup H. Epidemiologic and genetic aspects of spina bifida and other neural tube defects. Dev Disabil Res Rev. 2010;16(1):6-15.
[10]
10. Blom HJ, Shaw GM, den Heijer M, Finnell RH. Neural tube defects and folate: evidence from perspectives of pathways. Nat Rev Neurosci. 2006;7(9):724-731.